|
⚲
|
| Keyboard |
| Goldfischer Carl
✚
|
|
|---|---|
| CIK # | 0001110780 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001110780] | |
| 4 | [0001110780] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2025-06-18 | Grant | 1,440 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2024-06-20 | Grant | 36,000 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2023-06-14 | Grant | 36,000 | $0.00 | |
|
Epizyme Inc EPZM
Common Stock, par value $0.0001
|
2022-08-12 | Disposed to issuer | 3,380,951 | ||
|
Epizyme Inc EPZM
Common Stock, par value $0.0001
|
2022-08-12 | Disposed to issuer | 13,060 | ||
|
Epizyme Inc EPZM
Common Stock, par value $0.0001
|
2022-08-12 | Disposed to issuer | 8,994 | ||
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2022-06-14 | Grant | 36,000 | $0.00 | |
|
Enliven Therapeutics Inc IMRA
Stock Options (Right to Buy) · derivative
|
2022-06-02 | Grant | 8,500 | $0.00 | |
|
Epizyme Inc EPZM
Common Stock, par value $0.0001
|
2022-05-17 | Grant | 8,994 | $0.00 | |
|
Epizyme Inc EPZM
Stock Option (Right to Buy) · derivative
|
2022-05-17 | Grant | 41,006 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2021-11-17 | Grant | 18,000 | $0.00 | |
|
Enliven Therapeutics Inc IMRA
Stock Options (Right to Buy) · derivative
|
2021-06-29 | Grant | 7,728 | $0.00 | |
|
Epizyme Inc EPZM
Stock Option (Right to Buy) · derivative
|
2021-06-11 | Grant | 40,559 | $0.00 | |
|
Epizyme Inc EPZM
Common Stock, par value $0.0001
|
2021-06-11 | Grant | 8,060 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2021-05-26 | Grant | 18,000 | $0.00 | |
|
Epizyme Inc EPZM
Common Stock, par value $0.0001
|
2020-11-11 | Buy | 5,000 | $12.07 | 60,350 |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2020-11-02 | Conversion | 9,587 | ||
|
Damora Therapeutics Inc GLTO
Common Stock
|
2020-11-02 | Conversion | 1,020,036 | ||
|
Damora Therapeutics Inc GLTO
Common Stock
|
2020-11-02 | Conversion | 19,432 | ||
|
Damora Therapeutics Inc GLTO
Series C-3 Preferred Stock · derivative
|
2020-11-02 | Conversion | 7,475 | $0.00 | |
| showing 20 of 105 most recent transactions | |||||